Obesity Market to Witness a Robust Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Amgen, Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer, Raziel, Altimmune, Saniona, YSOPIA, Innovent
27 juin 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 27, 2023 (GLOBE NEWSWIRE) -- Obesity Market to Witness a Robust Growth by 2032, Assesses DelveInsight | Key Companies to Watch Out - Amgen, Novo Nordisk, Eli Lilly and Company,...
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
24 juin 2023 11h35 HE
|
Zealand Pharma
Press release – No. 6 / 2023 Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions Body weight reductions reached up to a mean...
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)
23 juin 2023 17h15 HE
|
Zealand Pharma
Press Release No. 5 / 2023 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with...
SciSparc and Clearmind Medicine to Conduct a Study Evaluating Their Combination Treatment for Obesity and Metabolic Syndrome
16 juin 2023 09h05 HE
|
SciSparc Ltd
The treatment combines SciSparc's Palmitoylethanolamide (PEA), the active pharmaceutical ingredient of its proprietary CannAmide™, and Clearmind’s MEAI, a novel proprietary psychedelic treatment for...
Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome
16 juin 2023 09h05 HE
|
Clearmind Medicine Inc.
The treatment combines Clearmind's MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc's Palmitoylethanolamide (PEA), the active ingredient of its proprietary...
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
09 juin 2023 09h30 HE
|
Clearmind Medicine Inc.
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, June 09, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
The India Edible Oil (Soybean, Palm, Cottonseed, Ground Nut, Sunflower, Sesame, Mustard, Coconut, Rice brand, Corn, Olive and Others) Market to reach INR 529639.18 Crore by 2027-28. – Bonafide Research
30 mai 2023 02h08 HE
|
Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, May 30, 2023 (GLOBE NEWSWIRE) -- India is blessed with many positive factors that enable it to stand in a unique position in Agro-based products. After achieving independence,...
Global Fitness Equipment Market is reach USD 16.47 Billion with anticipated CAGR of 5.14% for 2022-2027: Bonafide Research
26 mai 2023 09h08 HE
|
Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, May 26, 2023 (GLOBE NEWSWIRE) -- The fitness equipment industry is going through an impressive transformation driven by a strong focus on innovation and technological...
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
17 mai 2023 09h00 HE
|
Clearmind Medicine Inc.
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, May 17, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND),...
Boosting Brown Fat to Combat Obesity and Type 2 Diabetes
25 avr. 2023 08h00 HE
|
Purdue Research Foundation
WEST LAFAYETTE, INDIANA, April 25, 2023 (GLOBE NEWSWIRE) -- Eat less. Exercise more. It sounds so simple. But if it were that simple, America wouldn’t be facing the dual epidemics of obesity and...